The efficacy of curcumin-piperine co-supplementation on clinical symptoms, duration, severity, and inflammatory factors in COVID-19 outpatients: a randomized double-blind, placebo-controlled trial

ConclusionThe present study results showed that curcumin-piperine co-supplementation in outpatients with COVID-19 could significantly reduce weakness. However, in this study, curcumin-piperine co-supplementation could not significantly affect the other indices, including biochemical and clinical indices.Trial registrationIranian Registry of Clinical TrialsIRCT20121216011763N46. 2020-10-31

http://link.springer.com/10.1186/s13063-022-06375-w

Source: Trials - June 6, 2022 Category: Research Source Type: clinical trials